These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 27344366)

  • 41. Exosome-like Nanoparticles: A New Type of Nanocarrier.
    Fernandes M; Lopes I; Teixeira J; Botelho C; Gomes AC
    Curr Med Chem; 2020; 27(23):3888-3905. PubMed ID: 30706777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sequential Filtration: A Gentle Method for the Isolation of Functional Extracellular Vesicles.
    Heinemann ML; Vykoukal J
    Methods Mol Biol; 2017; 1660():33-41. PubMed ID: 28828646
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers.
    Maheshwari R; Tekade M; Gondaliya P; Kalia K; D'Emanuele A; Tekade RK
    Nanomedicine (Lond); 2017 Nov; 12(21):2653-2675. PubMed ID: 28960165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles.
    Kooijmans SAA; Stremersch S; Braeckmans K; de Smedt SC; Hendrix A; Wood MJA; Schiffelers RM; Raemdonck K; Vader P
    J Control Release; 2013 Nov; 172(1):229-238. PubMed ID: 23994516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi).
    Pan Q; Ramakrishnaiah V; Henry S; Fouraschen S; de Ruiter PE; Kwekkeboom J; Tilanus HW; Janssen HL; van der Laan LJ
    Gut; 2012 Sep; 61(9):1330-9. PubMed ID: 22198713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Arrowtail RNA for Ligand Display on Ginger Exosome-like Nanovesicles to Systemic Deliver siRNA for Cancer Suppression.
    Li Z; Wang H; Yin H; Bennett C; Zhang HG; Guo P
    Sci Rep; 2018 Oct; 8(1):14644. PubMed ID: 30279553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic Efficacy-Potentiated and Diseased Organ-Targeting Nanovesicles Derived from Mesenchymal Stem Cells for Spinal Cord Injury Treatment.
    Kim HY; Kumar H; Jo MJ; Kim J; Yoon JK; Lee JR; Kang M; Choo YW; Song SY; Kwon SP; Hyeon T; Han IB; Kim BS
    Nano Lett; 2018 Aug; 18(8):4965-4975. PubMed ID: 29995418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Delivery of Functional Small RNAs via Extracellular Vesicles In Vitro and In Vivo.
    Zhang D; Lee H; Jin Y
    Methods Mol Biol; 2020; 2115():107-117. PubMed ID: 32006397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Folate-displaying exosome mediated cytosolic delivery of siRNA avoiding endosome trapping.
    Zheng Z; Li Z; Xu C; Guo B; Guo P
    J Control Release; 2019 Oct; 311-312():43-49. PubMed ID: 31446085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isolation, identification, and characterization of novel nanovesicles.
    Zhang HG; Cao P; Teng Y; Hu X; Wang Q; Yeri AS; Zhuang X; Samykutty A; Mu J; Deng ZB; Zhang L; Mobley JA; Yan J; Van Keuren-Jensen K; Miller D
    Oncotarget; 2016 Jul; 7(27):41346-41362. PubMed ID: 27191656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo.
    Lee SJ; Yook S; Yhee JY; Yoon HY; Kim MG; Ku SH; Kim SH; Park JH; Jeong JH; Kwon IC; Lee S; Lee H; Kim K
    J Control Release; 2015 Dec; 220(Pt B):631-41. PubMed ID: 26307351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S; Benter I
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coincident Fluorescence-Burst Analysis of the Loading Yields of Exosome-Mimetic Nanovesicles with Fluorescently-Labeled Cargo Molecules.
    Sanaee M; Sandberg E; Ronquist KG; Morrell JM; Widengren J; Gallo K
    Small; 2022 Mar; 18(12):e2106241. PubMed ID: 35084110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exosome mimetics: a novel class of drug delivery systems.
    Kooijmans SA; Vader P; van Dommelen SM; van Solinge WW; Schiffelers RM
    Int J Nanomedicine; 2012; 7():1525-41. PubMed ID: 22619510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis.
    Schiffelers RM; Xu J; Storm G; Woodle MC; Scaria PV
    Arthritis Rheum; 2005 Apr; 52(4):1314-8. PubMed ID: 15818667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.
    Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Ohga N; Hida K; Harashima H
    J Control Release; 2014 Jan; 173():110-8. PubMed ID: 24120854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proof-of-Concept Study on the Use of Tangerine-Derived Nanovesicles as siRNA Delivery Vehicles toward Colorectal Cancer Cell Line SW480.
    Rabienezhad Ganji N; Urzì O; Tinnirello V; Costanzo E; Polito G; Palumbo Piccionello A; Manno M; Raccosta S; Gallo A; Lo Pinto M; Calligaris M; Scilabra SD; Di Bella MA; Conigliaro A; Fontana S; Raimondo S; Alessandro R
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exosome-mimetic nanoplatforms for targeted cancer drug delivery.
    Vázquez-Ríos AJ; Molina-Crespo Á; Bouzo BL; López-López R; Moreno-Bueno G; de la Fuente M
    J Nanobiotechnology; 2019 Jul; 17(1):85. PubMed ID: 31319859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles.
    Vader P; Crielaard BJ; van Dommelen SM; van der Meel R; Storm G; Schiffelers RM
    J Control Release; 2012 Jun; 160(2):211-6. PubMed ID: 21983283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exosome as a Novel Shuttle for Delivery of Therapeutics across Biological Barriers.
    Das CK; Jena BC; Banerjee I; Das S; Parekh A; Bhutia SK; Mandal M
    Mol Pharm; 2019 Jan; 16(1):24-40. PubMed ID: 30513203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.